BIOLIFE SOLUTIONS INC 8-K

What Happened

• BioLife Solutions, Inc. announced unaudited financial results and operational highlights for the quarter ended March 31, 2026 via a press release dated May 7, 2026. The company furnished that press release as Exhibit 99.1 to the Form 8-K filed the same day. The Form 8-K was signed by CFO Troy Wichterman.

Key Details

• Filing date: May 7, 2026; period covered: quarter ended March 31, 2026.
• Item reported: 2.02 (Results of Operations and Financial Condition) — the company announced quarterly results (unaudited).
• Exhibit filed: 99.1 — the May 7, 2026 press release; Inline XBRL cover page (Exhibit 104) also included.

Why It Matters

• This 8-K signals BioLife has provided its latest quarterly earnings and operating update; investors should read the press release for revenue, profit/loss, cash position and operational milestones.
• Because the results are unaudited and reported on Form 8-K (Item 2.02), they are a timely update ahead of any periodic SEC filings (like a Form 10-Q). Review the full press release or the company's EDGAR filing for specific financial figures and guidance.